SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Feb-24 5:00 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 22-Feb-24 | Grant | 50,000 | -- | -- | 113% 44.13K to 94.13K | |
22-Dec-23 5:30 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 21-Dec-23 | Sale | 1,400 | $8.50 | $11,900.00 | (3%) 45.53K to 44.13K | |
20-Dec-23 6:00 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 18-Dec-23 | Sale | 290 | $8.22 | $2,383.80 | (< 1%) 45.82K to 45.53K | |
21-Jun-23 4:17 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 20-Jun-23 | Market Sale | 291 | $12.94 | $3,765.54 | (< 1%) 46.11K to 45.82K | (13%) |
19-May-23 4:45 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 18-May-23 | Sale | 291 | $8.76 | $2,549.16 | (< 1%) 46.41K to 46.11K | |
20-Apr-23 4:30 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 18-Apr-23 | Sale | 290 | $10.71 | $3,105.90 | (< 1%) 46.7K to 46.41K | |
27-Mar-23 4:05 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 20-Mar-23 | Sale | 305 | $11.32 | $3,452.60 | (< 1%) 47.0K to 46.7K | |
21-Feb-23 6:54 PM View: | Cullinan Therapeutics, Inc. (CGEM) | 17-Feb-23 | Grant | 47,000 | -- | -- | 100% 0 to 47.0K | |
02-Jun-22 4:32 PM View: | Genocea Biosciences, Inc. (GNCA) | 01-Jun-22 | Sale | 2,500 | $0.06 | $150.25 | (5%) 45.5K to 43.0K | |
17-Mar-22 4:17 PM View: | Genocea Biosciences, Inc. (GNCA) | 15-Mar-22 | Grant | 37,500 | -- | -- | 469% 8.0K to 45.5K |